Skip to main content

Most Popular Diabetes News

The FDA has approved Provention Bio’s Tzield (teplizumab), a new therapy that could delay the onset of type 1 diabetes by an average of 2 years. Find out about screening...
Mounjaro, a drug approved in 2022 to treat type 2 diabetes, has also shown remarkable weight-loss effects, reducing trial participants’ weight by over 20%. Regulators...
The first large-scale launch of the highly anticipated Dexcom G7 continuous glucose monitor (CGM) has officially begun. The next-generation CGM is now available in...
About 200 million people with diabetes around the world require daily insulin. Once-weekly basal insulins, if approved, could require fewer injections and potentially...
The term “type 2 diabetes remission” continues to spark debate in the diabetes community. At the EASD 2022 annual conference in Stockholm, experts explored this concept...
Having diabetes puts you at risk for nerve damage in your extremities – a condition known as peripheral neuropathy. Here are steps you can take to maintain the health of...
The recently passed Inflation Reduction Act includes new policies that cap the monthly cost of insulin at $35 and potentially reduce the cost of other diabetes drugs for...
Impressive results from a trial for an up-and-coming artificial pancreas showed that users spent an average of 2.6 more hours in range each day compared to non-users –...
Earlier this week, Dexcom announced its decision to re-submit the software for the much-anticipated G7, pushing back the US launch date until later in 2022. Here’s why...
Yogurt is a common dairy food, but with so many varieties and flavors, it’s hard to know which ones are the best for someone with diabetes. Learn more about the...
For many years, a cure for type 1 diabetes has only been a pipe dream for the millions of people living with type 1 diabetes. New data from Vertex Pharmaceuticals on the...
Mounjaro (tirzepatide), a first-of-its kind medication for treating type 2 diabetes, has been approved by the FDA after much anticipation. This new medication has been...
The FDA approved Ozempic for a 2.0 mg dose, which was based on clinical trial data showing the higher dose led to a better A1C and to weight loss.
In October 2022, Dexcom announced that its next-generation continuous glucose monitor (CGM), Dexcom G7, is now available to people with diabetes in Hong Kong and several...
Trying to learn how to lower morning blood sugar? Here are the reasons why your glucose levels rise in the morning and how you can keep them in range.
The American Diabetes Association released its 2022 Standards of Care, which provides an annual update on practice guidelines. Here's what these new updates mean,...
While you are likely familiar with metformin and insulin as the two well-known medications for treating type 2 diabetes, many other options are available to help you...
Looking for the right gift for a loved one with diabetes? Here’s a helpful list to get your holiday shopping started – from helpful gadgets to food plan subscriptions...
We’ve reviewed the latest research to weigh the benefits and drawbacks of intermittent fasting and time-restricted feeding for people with diabetes.
Wegovy, a once-weekly injectable medication (semaglutide), has been approved by the FDA to treat obesity and excess weight – conditions that can lead to type 2 diabetes...

Pages